|
Association of British Clinicial Diabetologists
& Welsh Endocrine & Diabetes Society
Spring Meeting "Now that's what I call Diabetes and Endocrinology"
Hilton Cardiff, 23rd & 24th April 2015
POSTERS FOR ONLINE VIEWING
1 Whole genome sequence based analysis of thyroid function
Peter N. Taylor(1)*, Eleonora Porcu(2,3,4)*, Shelby Chew(5)*, Purdey J. Campbell(5)*, Michela Traglia(6),, Suzanne J. Brown(5), Benjamin H. Mullin(5),(7), Hashem A. Shihab(8), Josine L. Min(8), Klaudia Walter(9), Yasin Memari(9), Jie Huang(9), Michael R. Barnes(10), John P. Beilby(11),(12), Pimphen Charoen(13),(14), Petr Danecek(9), Frank Dudbridge(13), Vincenzo Forgetta(15),(16), Celia Greenwood(15),(16), Elin Grundberg(17),(18), Andrew D. Johnson(19), Jennie Hui(11),(12), Ee M. Lim(5),(11), Shane McCarthy(9), Dawn Muddyman(9), Vijay Panicker(5), John R.B. Perry(20),(21), Jordana T. Bell(21), Wei Yuan(21), Caroline Relton(8), Tom Gaunt(8), David Schlessinger(22), Goncalo Abecasis(4), Francesco Cucca(2),(3), Gabriela L. Surdulescu(21), Wolfram Woltersdorf(23), Eleftheria Zeggini(9), Houfeng Zheng(15),(16), Daniela Toniolo(6),(24), Colin M. Dayan(1), Silvia Naitza(2), John P. Walsh(5),(7), Tim D. Spector(21), George Davey Smith(8), Richard Durbin(9), J. Brent Richards(15),(16),(21), Serena Sanna(2), Nicole Soranzo(9), Nicholas J. Timpson(8)*, Scott G. Wilson(5),(7),(21)* and the UK10K Consortium(25).
* Authors contributed equally.
(1) Thyroid Research Group, Institute of Molecular & Experimental Medicine, Cardiff University School of Medicine, Cardiff University, Cardiff, United Kingdom:2) Istituto di Ricerca Genetica e Biomedica (IRGB), Consiglio Nazionale delle Ricerche, c/o Cittadella Universitaria di Monserrato, Monserrato, Cagliari, Italy;
(3) Dipartimento di Scienze Biomediche, Università di Sassari, Sassari, Italy;
(4) Center for Statistical Genetics, Biostatistics Department, University of Michigan, Ann Arbor, MI, USA;
(5) Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia;
(6) Division of Genetics and Cell Biology, San Raffaele Research Institute, Milano, Italy;
(7) School of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia;
(8) MRC Integrative Epidemiology Unit at the University of Bristol, University of Bristol, Bristol, United Kingdom;
(9) Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom;
(10) William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom;
(11) Pathwest Laboratory Medicine WA, Nedlands, Western Australia, Australia;
(12) School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia;
(13) Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom;
(14) Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand;
(15) Department of Medicine, Jewish General Hospital, McGill University, Montréal Québec, Canada;
16) Departments of Human Genetics, Epidemiology, and Biostatistics, Jewish General Hospital, Lady Davis Institute, McGill University, Montréal Québec, Canada;
17) Department of Human Genetics, McGill University, Montreal, QC H3A1A5, Canada;
(18) McGill University and Genome Quebec Innovation Centre, Montreal, QC H3A1A5, Canada;
(19) Cardiovascular Epidemiology and Human Genomics Branch, National Heart, Lung and Blood Institute, Bethesda, MD, USA;
(20) MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine,Box 285, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, United Kingdom;
(21) Department of Twin Research and Genetic Epidemiology, King’s College London, London, United Kingdom;
22) Laboratory of Genetics, NIA, Baltimore, MD 21224, USA;
(23) Facharzt für Laboratoriumsmedizin, Geschäftsführer amedes Ost, Halle/Leipzig GmbH, Leipziger Chaussee 191f, 06112 Halle (Saale), Germany;
(24) Institute of Molecular Genetics–CNR, Pavia, Italy
Poster not provided for on line viewing
2 Reliability of a post partum fasting glucose in the management of women with gestational diabetes
Peter N Taylor(1),(2), Gautam Das(1), Arshiya Tabsum(1), Elizabeth Bradley(1), David Burberry(1)Dawn Lee(1) Piero Baglioni(1), Anthony Robinson(3), Onyebuchi E Okosieme(1),(2)
(1)Endocrinology and Diabetes Department, Prince Charles Hospital, Cwm Taf University Health Board, Merthyr Tydfil;
(2) Institute of Molecular and Experimental Medicine, Cardiff University School of Medicine, Cardiff;
(3) Department of Diabetes and Endocrinology, Royal United Hospital, Bath.
Click here to view poster
3 Dapagliflozin is more effective in the most poorly controlled diabetic
T Min(1), (2), A Dixon(2), A Mallipedhi(1), P Varnavas(2), C McIver(1), D Price(1), J Stephens(1), J Harvey(2)
(1)Department of Diabetes and Endocrinology, Morriston Hospital, Swansea, SA6 6NL;
(2)Department of Diabetes and Endocrinology, Wrexham Maelor Hospital, Wrexham, LL13 7TD
Click here to view poster
4 Correlations between cardiovascular risk factors and TBPI v Doppler in patients with type2 diabetes
L Lomova-Williams(1), A Mallipedhi(1),(2), D E Price(1), R Thomas(1), C Ferguson(1),(2), S Bain(1),(2), J W Stephens(1),(2)
(1)Department of Diabetes & Endocrinology, Morriston Hospital, ABM University Health, Swansea SA6 6NL;
(2) Diabetes Research Group, Institute of Life Sciences, Swansea University SA2 8PP
Click here to view poster
5 Pancreatic Enzyme supplmentation in diabetes
Witczak JK(1), Evans PJ(1) (1) Royal Gwent Hospital, Aneurin Bevan Health Board
Click here to view poster
6 Local pregnancy and foetal outcomes in GDM in Gloucestershire
Emily Renninson(1), Sarah Murray(1), Tripti Mahajan(1)
(1)Diabetes and Endocrinology Department, Gloucester Royal Hospital, Great Western Road, Gloucester GL1 3NN
Poster not provided for on line viewing
7 Cardiovascular risk prediction in subjects at high risk of type 2 diabetes mellitus: Do different risk predictors give the same results
L Lomova-Williams(1), A Mallipedhi(1),(2), R Tristham(3), G Lake(3), J W Stephens(1),(2)
(1) Department of Diabetes & Endocrinology, Morriston Hospital, ABM University Health, Swansea SA6 6NL;
(2) Diabetes Research Group, Institute of Life Sciences, Swansea University SA2 8PP;
(3) Clydach Primary Care Centre, Clydach, Swansea, SA6 5LN.
Click here to view poster
8 Clinical testing of an internet web based tool for risk assessment and management of IP with diabetes
M Choudhary(1), K Boregowda(1), H Bolusani(1) & A Roberts(1)
(1)Department of Diabetes and Endocrinology, University Hospital of Wales, Cardiff
Click here to view poster
9 All Wales audit and real world outcomes on the use of Dapagliflozin in the management of T2DM
V S Eligar(1), M Nassrullah(1),S Zouras(2), S Rice(2), A Kalhan(1), A Roberts(1) and H Bolusani(1)
(1)University Hospital of Wales, Cardiff, 2Prince Philip Hospital
Click here to view poster
10 Type 2 diabetes, basal Insulin and the experience of hypos: Insights from the patient perspective
Jen Nash(1), Amar Ali(2), Grace Vanterpool(3), Philippa Hammerton(4), Richard Hudson(5)
(1) Chartered Psychologist with the British Psychological Society, Director of ‘Positive diabetes’;
(2) GPWSI Diabetes, Oakenhurst Surgery, Blackburn;
(3)Diabetes Nurse Consultant, London Northwest Healthcare NHS Trust;
(4)RedLeaf Research Limited, Guildford; (5)Sanofi, Guildford, United Kingdom
Click here to view poster
11 Awareness of driving regulations and safe driving requirements for people with Insulin treated diabetes: Health Care Professional Perspectives
Thinzar Min(1)
(1) Diabetes Department, Morriston Hospital, Swansea
Click here to view poster
12 Experience with Dapagliflozin at the Royal Cornwall Hospital
Michael Gilroy(1)
(1)Endocrinology and Diabetes, Royal Cornwall Hospital Treliske, Truro
Click here to view poster
13 HES data, patient experience and local statistics - can peer reviews of diabetes foot care services improve outcomes
Richard Paisey(1)
(1) Horizon Centre, Torbay Hospital, Torquay, TQ2 7AA
Click here to view poster
14 Audit of the outcomes of adding an SGLT2 inhibitor to Insulin in sub optimally controlled T2DM patients
L S Cozma(1), S Benjamin(1), S Roy-Chawdhury(1)
(1)Diabetes Centre, Princess of Wales Hospital, ABMU Health Board, Bridgend, South Wales
Click here to view poster
15 Weight change and sustained improvement in glyceamic control over 5 years in patients with T2DM on U500 Insulin
Umesh Dashora(1), Erwin Castro(1)
(1) Conquest Hospital, Hastings
Poster not provided for on line viewing
16 Injection site reaction secondary to GLP1 therapy
P Srivatsava(1), K Boregowda(1), M Choudhury(1), Aled Roberts(1), Hemanth Bolusani(1)
(1)Department of Diabetes and Endocrinology, University Hospital of Wales, Cardiff
Click here to view poster
17 Hyperglycemia post pancreas transplantation in a case of Alstrom's syndrome with diabetes
M Choudhary(1), K Boregowda(1), A Roberts(1), H Bolusani(1), C Dayan(1)
(1) Department of Diabetes and Endocrinology, University Hospital of Wales, Cardiff
Click here to view poster
18 Cushings Syndrome in assocaition with Osteoporosis
Pranav Kumar(1), Maneesh Udiawar(1), Santosh Shankarnarayan(1), David Price(1)
(1) Morriston Hospital , Swansea SA6 6NL
Click here to view poster
19 The weekly injection: A practical soultion to an old crisis
Peter Taylor(1),(2), Arshiya Tabasum(1), John Geen(1), Gina Sanki(1), Brian Tennant(1), Andrew Aldridge(1), Onyebuchi Okosieme(1),(2) and Gautam Das(1)
(1) Endocrinology and Diabetes Department, Prince Charles Hospital, Cwm Taf University Health Board, Merthyr Tydfil;
(2)Institute of Molecular and Experimental Medicine, Cardiff University School of Medicine, Cardiff.
Click here to view poster
20 An unexplained case of chronic back pain: A large Pheochromocytoma in a 55 year old women
Stamatios Zouras(1), Sam Rice(1), Jayne Evans(1), Tom N W Evans(1)
(1)Prince Philip Hospital, Mawr Dafen Road, Llanelli, Carmarthenshire Click here to view poster |
